跳至主要内容
临床试验/CTRI/2023/02/050027
CTRI/2023/02/050027已完成4 期

Oral Dextrose Gel for Treatment of Neonatal Hypoglycemia: An Open Labelled Randomised Control Trial

Kasturba Medical College, MAHE0 个研究点目标入组 193 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
193

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • All asymptomatic neonates, >35 weeks of gestation with hypoglycemia (blood glucose levels <50mg/dl) in the first 48 hours of life, admitted at Kasturba Hospital, Manipal with any of the following risk factors
  • NEONATAL FACTORS
  • Small for gestation (SGA) (Birth weight <10th centile or <2500g)
  • Large for gestation (LGA) (Birthweight >90th centile or >4000g)
  • Intrauterine growth restriction (IUGR)
  • Discordant twin : Weight 20% less than the larger twin
  • Late preterm (35-36 weeks)
  • Poor feeding
  • Hypothermia
  • MATERNAL FACTORS
  • IDM : Gestational DM, Type 1 DM or Type 2 DM
  • Maternal hypertension treated with Beta blockers
  • Maternal Pre-eclampsia
  • Maternal Eclampsia

排除标准

  • 1.Neonates with:
  • i.Any high-risk neonate admitted to NICU for any other reason
  • ii.Perinatal asphyxia
  • iii.Early onset sepsis
  • iv.Critically ill neonates (pH <6.8 or hypoxia with persistent bradycardia)
  • v.Chromosomal disorders
  • vi.Congenital malformations
  • vii.Surgical conditions –like intestinal obstruction/perforation needing stoma and mucus fistula
  • viii.Neonates with congenital or maternal infections
  • 2.Parents who deny consent

研究者

发起方
Kasturba Medical College, MAHE

相似试验